Molecular Biology in Medicinal Chemistry
Theodor Dingermann · Dieter Steinhilber · Gerd Folkers · Raimund Mannhold · Hugo Kubinyi
thg 3 2006 · John Wiley & Sons
Sách điện tử
435
Trang
reportĐiểm xếp hạng và bài đánh giá chưa được xác minh Tìm hiểu thêm
Giới thiệu về sách điện tử này
Die Gentechnik hat nicht nur die moderne Biologie sondern auch die Pharmaforschung revolutioniert. Mit den Methoden der Molekularbiologie stehen heute ganz neue Verfahren fur die Entwicklung, Herstellung und Analytik von Wirkstoffen zur Verfugung. Dieser Band beschreibt anhand vielfaltiger Beispiele die erfolgreiche Anwendung molekularbiologischer Methoden in der Pharmaforschung.
Das Themenspektrum reicht von rekombinanten "drug targets" uber gentechnisch hergestellte Medikamente bis hin zum Einsatz molekularbiologischer Techniken in der Enantiomerentrennung. Neue Verfahren der Probenvorbereitung, der kombinatorischen Synthese und der Pharmakokinetik werden ebenso vorgestellt wie die molekularbiologisch gepragten Konzepte des funktionellen Wirkortes und der Pharmakogenomik.
Renommierte Herausgeber und Autoren beleuchten den aktuellen Stand der Forschung und erlautern die Moglichkeiten und Grenzen der neuen Techniken. Dieses verstandlich geschriebene Buch wendet sich an alle Chemiker, Pharmazeuten, Molekularbiologen und Mediziner, die sich mit der modernen Wirkstoffforschung beschaftigen.
Giới thiệu tác giả
Theodor Dingermann, born 1948, studied pharmacy at the University of Erlangen, Germany. After obtaining his PhD in biochemistry, he worked as a post-doc at Yale University, New Haven. In 1987 he completed his habilitation for the disciplines of biochemistry and molecular biology. Since 1990 he is full professor of pharmaceutical biology at Goethe University in Frankfurt, Germany. He is editor-in-chief of two journals, "Die Pharmazie" and "Pharmazie in unserer Zeit". Furthermore, he is chairman of the working group on biopharmaceuticals and vice-chairman of the committee on pharmaceutical biology of the German Arzneibuch commission. From 2000 to 2004 he has been President of the German Pharmaceutical Society.
Dieter Steinhilber, born 1959, studied pharmacy at the University of Tubingen (Germany). After an assistantship there he spent a postdoc period with Nobel prize winner Bengt Samuelsson in Stockholm (Sweden). In 1994 he received an associate professorship and since 2000 he is a full professor for pharmaceutical chemistry at the Goethe University in Frankfurt (Germany). He is also the chairman of the scientific advisory board of Phenion, a company for molecular cell physiology.
Gerd Folkers is professor of pharmaceutical chemistry at the ETH Zurich since 1991. He studied pharmacy at the University of Bonn and earned his Ph.D. on structure-activity relationships of desapurines. He then moved to the University of Tubingen, where he completed his habilitation in pharmaceutical chemistry. During a stay with H.-D. Hoeltje in Bern, he studied new research methods in computer-aided molecular design and expanded this knowledge during other stays with T. Blundell at the Birkbeck College and E. Meyer at Texas A&M University.
The focus of his research is the molecular interaction between drugs and their binding sites. Besides his work on the molecular mechanism of "conventional" nucleoside therapeutics against virus infections and cancer, his special interest has shifted to immuno-therapeutics.
Dieter Steinhilber, born 1959, studied pharmacy at the University of Tubingen (Germany). After an assistantship there he spent a postdoc period with Nobel prize winner Bengt Samuelsson in Stockholm (Sweden). In 1994 he received an associate professorship and since 2000 he is a full professor for pharmaceutical chemistry at the Goethe University in Frankfurt (Germany). He is also the chairman of the scientific advisory board of Phenion, a company for molecular cell physiology.
Gerd Folkers is professor of pharmaceutical chemistry at the ETH Zurich since 1991. He studied pharmacy at the University of Bonn and earned his Ph.D. on structure-activity relationships of desapurines. He then moved to the University of Tubingen, where he completed his habilitation in pharmaceutical chemistry. During a stay with H.-D. Hoeltje in Bern, he studied new research methods in computer-aided molecular design and expanded this knowledge during other stays with T. Blundell at the Birkbeck College and E. Meyer at Texas A&M University.
The focus of his research is the molecular interaction between drugs and their binding sites. Besides his work on the molecular mechanism of "conventional" nucleoside therapeutics against virus infections and cancer, his special interest has shifted to immuno-therapeutics.
Xếp hạng sách điện tử này
Cho chúng tôi biết suy nghĩ của bạn.
Đọc thông tin
Điện thoại thông minh và máy tính bảng
Cài đặt ứng dụng Google Play Sách cho Android và iPad/iPhone. Ứng dụng sẽ tự động đồng bộ hóa với tài khoản của bạn và cho phép bạn đọc trực tuyến hoặc ngoại tuyến dù cho bạn ở đâu.
Máy tính xách tay và máy tính
Bạn có thể nghe các sách nói đã mua trên Google Play thông qua trình duyệt web trên máy tính.
Thiết bị đọc sách điện tử và các thiết bị khác
Để đọc trên thiết bị e-ink như máy đọc sách điện tử Kobo, bạn sẽ cần tải tệp xuống và chuyển tệp đó sang thiết bị của mình. Hãy làm theo hướng dẫn chi tiết trong Trung tâm trợ giúp để chuyển tệp sang máy đọc sách điện tử được hỗ trợ.
